Targeting fusions for improved outcomes in oncology treatment

Background Fusions are increasingly pursued as oncology therapeutic targets. The current study evaluated differences in outcomes for fusion versus nonfusion targets. Methods Outcomes were compared for patients with fusions versus those with other alterations for US Food and Drug Administration–approved single agents (from package inserts) and for patients treated at the University of California at San Diego. Results A total of 28 drugs approved...